Cholesterol-dependent generation of a unique amyloid beta-protein from apically missorted amyloid precursor protein in MDCK cells.

[1]  Y. Ihara,et al.  Amyloid β‐protein (Aβ) associated with lipid molecules: immunoreactivity distinct from that of soluble Aβ , 1997 .

[2]  N. Hooper,et al.  The Amyloid Precursor Protein Is Not Enriched in Caveolae‐Like, Detergent‐Insoluble Membrane Microdomains , 1997, Journal of neurochemistry.

[3]  Y. Ihara,et al.  Intracellular Generation and Accumulation of Amyloid β-Peptide Terminating at Amino Acid 42* , 1997, The Journal of Biological Chemistry.

[4]  E. Ikonen,et al.  Functional rafts in cell membranes , 1997, Nature.

[5]  C. Masters,et al.  Intracellular and secreted Alzheimer beta-amyloid species are generated by distinct mechanisms in cultured hippocampal neurons. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[6]  P. Ianna,et al.  Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content. , 1997, The Biochemical journal.

[7]  S. Prusiner,et al.  Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Hans Förstl,et al.  Analysis of Heterogeneous βA4 Peptides in Human Cerebrospinal Fluid and Blood by a Newly Developed Sensitive Western Blot Assay* , 1996, The Journal of Biological Chemistry.

[9]  A. Prochiantz,et al.  Axonal Amyloid Precursor Protein Expressed by Neurons in Vitro Is Present in a Membrane Fraction with Caveolae-like Properties (*) , 1996, The Journal of Biological Chemistry.

[10]  W. Klein,et al.  Cholesterol Modulates -Secretase Cleavage of Amyloid Precursor Protein (*) , 1996, The Journal of Biological Chemistry.

[11]  M Murata,et al.  VIP17/MAL, a proteolipid in apical transport vesicles , 1995, FEBS letters.

[12]  J. Seelig,et al.  Self-association of beta-amyloid peptide (1-40) in solution and binding to lipid membranes. , 1995, Journal of molecular biology.

[13]  Y. Ihara,et al.  GM1 ganglioside–bound amyloid β–protein (Aβ): A possible form of preamyloid in Alzheimer's disease , 1995, Nature Medicine.

[14]  G. Meer,et al.  Intracellular lipid heterogeneity caused by topology of synthesis and specificity in transport. Example: sphingolipids , 1995 .

[15]  S. Prusiner,et al.  Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform [published erratum appears in J Cell Biol 1995 Jul;130(2):501] , 1995, The Journal of cell biology.

[16]  D. Selkoe,et al.  Polarized sorting of beta-amyloid precursor protein and its proteolytic products in MDCK cells is regulated by two independent signals , 1995, The Journal of cell biology.

[17]  T. Iwatsubo,et al.  High tissue content of soluble beta 1-40 is linked to cerebral amyloid angiopathy. , 1994, The American journal of pathology.

[18]  S. Squazzo,et al.  Evidence that production and release of amyloid beta-protein involves the endocytic pathway. , 1994, The Journal of biological chemistry.

[19]  G Klopman,et al.  Solution structure of residues 1-28 of the amyloid beta-peptide. , 1994, Biochemistry.

[20]  S. Younkin,et al.  An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. , 1994, Science.

[21]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[22]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[23]  H. Mantsch,et al.  Comparative Analysis of Human and Dutch-Type Alzheimer β-Amyloid Peptides by Infrared Spectroscopy and Circular Dichroism , 1993 .

[24]  J. Reed,et al.  Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease beta A4 peptides. , 1992, Journal of molecular biology.

[25]  D. Selkoe,et al.  Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments , 1992, Nature.

[26]  L. Herbette,et al.  Evidence for changes in the Alzheimer's disease brain cortical membrane structure mediated by cholesterol , 1992, Neurobiology of Aging.

[27]  I. Mellman,et al.  Selective inhibition of transcytosis by brefeldin A in MDCK cells , 1991, Cell.

[28]  C. Barrow,et al.  Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition. , 1991, Science.

[29]  J. Reed,et al.  Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease , 1991 .

[30]  R. G. Anderson,et al.  Cholesterol controls the clustering of the glycophospholipid-anchored membrane receptor for 5-methyltetrahydrofolate , 1990, The Journal of cell biology.

[31]  G van Meer,et al.  Lipid sorting in epithelial cells. , 1988, Biochemistry.

[32]  K. Grzeschik,et al.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.

[33]  A. D. Roses,et al.  Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease , 2006 .

[34]  H. Mantsch,et al.  Human and rodent Alzheimer beta-amyloid peptides acquire distinct conformations in membrane-mimicking solvents. , 1993, European journal of biochemistry.

[35]  E. Rodriguez-Boulan,et al.  Polarity of epithelial and neuronal cells. , 1992, Annual review of cell biology.

[36]  L. Otvos,et al.  Is amyloid deposition in Alzheimer's disease preceded by an environment-induced double conformational transition? , 1989, Peptide research.